Why Analyze the Tumor Immune Microenvironment?
The tumor microenvironment (TME) is a complex ecosystem where tumor cells, immune cells, stromal cells, and signaling molecules interact to shape disease progression and therapeutic response. A thorough understanding of the tumor immune microenvironment (TIME) is essential for identifying mechanisms of immune evasion, predicting immunotherapy outcomes, and rationally designing combination strategies.
Our Tumor Immune Microenvironment Analysis Service provides a comprehensive, project-specific approach to profiling the cellular and molecular composition of the TME. Depending on your research questions, we employ orthogonal techniques including NGS-based transcriptomics (bulk and single-cell RNA-seq, TCR repertoire sequencing) and protein-level analyses such as multiplex immunofluorescence, immunohistochemistry, and qPCR immunophenotyping. This integrated methodology enables quantification of tumor-infiltrating lymphocytes (TILs), assessment of immune activation or exhaustion markers, and spatial mapping of cell–cell interactions within the tissue context.
Whether your goal is to monitor immune infiltration in patient-derived xenografts, evaluate T cell clonal expansion in syngeneic models, or identify biomarkers of response in clinical trial samples, our service delivers actionable data to guide your preclinical and translational immuno-oncology programs.
Integrated Analysis Options
Immune Cell Profiling
Quantify immune cell subsets (T cells, B cells, NK cells, macrophages, MDSCs, etc.) and their functional states using RNA-seq deconvolution or targeted qPCR panels.
TCR Repertoire Analysis
Assess T cell clonality, diversity, and expansion by bulk or single-cell TCR sequencing, with optional antigen specificity annotation.
Spatial Context Mapping
Visualize and quantify the spatial distribution of immune cells relative to tumor cells using multiplex immunofluorescence or digital pathology.
Stromal and ECM Profiling
Characterize cancer-associated fibroblasts, endothelial cells, and extracellular matrix components to understand how the stromal compartment influences tumor immunity and therapy response.
How It Works
Service Scope
| Parameter | Typical Project Scope |
|---|---|
| Sample Material | Fresh, frozen, or FFPE tissue; single-cell suspensions; blood; or isolated immune cells |
| Immune Cell Type Coverage | Customizable panels are available to cover major immune cell types including T cells (CD4+, CD8+, Treg), B cells, NK cells, macrophages (M1/M2), MDSCs, dendritic cells, and granulocytes, as scoped per project. |
| Method Integration | Depending on project scope, we integrate complementary technologies including bulk RNA-seq, single-cell RNA-seq, TCR repertoire sequencing, multiplex immunofluorescence, immunohistochemistry, qPCR immunophenotyping, and spatial transcriptomics. |
| Data Deliverables | Deliverables include cell-type quantification (counts and percentages), immune activation/exhaustion marker expression, TCR clonality and diversity indices, and spatial proximity metrics between immune and tumor cells. |
| QC Metrics | QC metrics provided include RNA integrity number (RIN), library complexity, sequencing saturation, and antibody validation data to ensure data quality and reproducibility. |
Why Our Service
Multi-Platform Integration
We combine transcriptomic (NGS) and proteomic (MIF/IHC/qPCR) approaches within a single project, enabling cross-validation and a more complete view of the TME than any single method alone.
Project-Scoped Flexibility
Each analysis plan is designed around your specific model system, sample type, and endpoints, rather than forcing your study into a fixed package. Scope is finalized after consultation.
Responsive Bioinformatics Support
Our bioinformatics team provides custom data analysis, including cell-type deconvolution, clonality analysis, and spatial statistics, with interactive visualizations and written interpretation.
Experienced Immuno-Oncology Team
Our scientists have deep experience in tumor immunology and TME characterization across both preclinical models and clinical samples, ensuring that your data meets the rigor required for regulatory submissions.
Featured Resource
Protocol
Protocol to characterize the melanoma tumor immune microenvironment in mice from single cell to flow cytometry analysis
View articleReady to Characterize Your Tumor Immune Microenvironment?
Contact our team to discuss your specific immune profiling needs, sample types, and research endpoints, and we will design a customized analysis plan tailored to your preclinical timeline and budget constraints.